Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study (vol 144, pg 341, 2021)

초록

The authors regret that the numbers of bone metastasis in this LEO trial (Table 1) need to be corrected as follows: Bone meta 59 (64.1)--> 66 (71.7)in the EVE arm. 27 (60.0)--> 31 (71.1) in the LET arm. Please find the correct Table 1 below. These corrections do not affect any description in the published article. The authors would like to apologise for any inconvenience caused.